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Guanidine hydrochloride was tested for its potential to produce sensitization via contact with the skin. Testing was performed on male guinea p by using nitroguanidine and intermediates/by-products of its manufacture, In accordance with the Toxic Substances Control Act regulations promulgated by the Environmental Protection Agency (EPA). One of the by-products to be tested is guanidine. The hydrochloride salt was used in this evaluation of the potential of guanidine to produce dermal sensitization. positive control substance information is presented in Appendix A.
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Animal Data
Forty-six male guinea pigs, Hartley strain, (Charles River Breeding Laboratories, Wilmington, MA) were studied. They were identified individually with ear tags numbered 84EO001 -84E0046, inclusive. Two animals, the smallest and one showing mild clinical signs, were selected for quality control necropsy evaluation on receipt.
Four of the animals were tested in a pilot study to determine a non-irritating dose level.
Animal weights on receipt (10 May 84) ranged from 186 to 234 g. Additional animal data appear la Appendix B.",
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METHODS
This study was conducted in accordance with LAIR SOP-OP-STX-82 "'Buehler Dermal Sensitization Test" (1) and EPA guidelines (2).
Group _Asinment/Acc 1 ma t ion
The guinea pigs were quarantined for 13 days before administration of the first induction dose. During the quarantine period, they were checked daily for signs of illness and weighed once a week. Ten animals were assigned to each of four groups by a stratified randomization technique based on their body weights.
Dosage Levels
Guanidine hydrochloride was applied as a 10% solution in isotonic saline. A pilot study, using 100%, 10%, 1%, and 0.1% concentrations, indicated the 10% solution to be the highest non-irritating concentration under the conditions of this test.
Two sensitization control groups were included in the study. Dinirrochlorobenzene, a known potent sensitizing agent (3), was applied to one group, at a 0.1% concentration, as a positive control. Isotonic saline was applied to another group as a vehicle control. In addition, a negative control group received guanidine hydrochloride only on the day of challenge dosing.
Compound repat ion
Guanidine hydrochloride was readily soluble in isotonic saline. The dinitrochlorobenzene dosing solution was prepared by first adding 30 mg DNCB to I ml of propylene glycol and heating until it dissolved (approximately 40 0 C). To this, 29 ml of 0.9% sodium chloride solution were added, to give a final concentration of 0.1% (w/v). This solution was heated to 65*C and vortexed before application to keep % the I)NCB in solution. DNCB solutions were prepared fresh for each application day.
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Test Procedures O .
The closed patch dermal sensitization test procedures utilized in this study were developed by Buehler and Griffith (4-6) to approximate Of the human repeated insult patch test procedures (7) . Test compounds were applied for 6 h under a closed patch once a week for 3 weeks during the induction phase. The same application site was used for insult and sensitization, duplicate patches of the challenge dose were applied, one on the old site and one on a new site. To distinguish.'. between reactions from primary irritation and sensitization, negative control groups were added which received only the challenge dose. k During the induction phase, the experimental, saline control, and e positive control groups were dosed with 0.5 ml of the appropriate compound applied topically under a I-in (2.5 cm) square gauze patch. This procedure was performed for three consecutive weeks (23 May, 30 May, and 6 Jun 84).
The day before each dosing a 3-in (7.6 cm) square area on the left side of the animal was clipped with electric clippers When the wrap and patch were removed, the area under the patch was marked off for scoring.
Animals were challenged 2 weeks (20 Jun 84) following the third induction dose. The experimental group and the positive control group received two 0.5 ml doses, one applied to the old site on the left side and the other to a new site on the right side. Negative and vehicle control groups only received a single 0.5 ml dose which was "' -applied to the left side. The procedures for clipping, shaving, ., wrapping, and exposure period remained the same. In Buehler's procedure (4-6), skin reactions are scored 24 and c.,. 2 48 h after the challenge dose only. In the present study, skin reactions were scored 24 and 48 h after each induction dose as well.
Skin reactions were assigned scores according to Buehler's grading system: 0 (no reaction), 1 (slight erythema), 2 (moderate erythema) and 3 (marked erythema). The results are expressed both in terms of incidence (the number of animals showing responses of I or greater at either 24 or 48 h) and severity (the sum of the test scores divided by the number of animals tested). Results from the left side are compared with right side and with the negative control group.
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Some modifications of Buehler's procedures were made. Instead of placing animals in restraint during the 6-h exposure period, the animals were wrapped several times with an elasticized tape to hold the patch in place. Consequently, the animals were able to move about freely in their cage during the exposure period. Buehler and Griffith (6) also recommended depilating the day before the challenge dose is applied. For consistency with induction procedures, this step was replaced by clipping and shaving a 3-in (7.6 cm) square area on the left side of the animals the day before dosing.
A historical listing of study events appears in Appendix C.
Deviations from Study Protocol
A 0.5 level (very slight erythema) was added to the scoring system to allow for borderline responses.
The DNCB solution was maintained at approximately 65°C before dosing. This was necessary to keep the DNCB in solution, but did not result in thermal insult to the animals' skin as the aliquot for dosing cooled quickly during pipetting and application to the patch. Significant sensitization was produced by DNCB with this method.
At the time of the first induction dose, the water supply to the animals was interrupted (0900 h 23 May to 0700 h 24 May). Close inspection of the animals immediately thereafter showed them all to be healthy and normal. No health problems or unusual behaviors were evident at this or any later time in the study.
Also at the first induction dose, one positive control animal remained patched with DNCB for approximately 22 h. This animal I! (84E0035) was, upon close inspection, found to be healthy and normal after patch removal. Response to DNCB in this animal was borderline (0.5 grade) at this and later times in the study.
These deviations from the protocol did not adversely affect study results.
RESULrTs fables 1 and 2 summarize the incidence of reactions 24 and 48 h after each dose. Except for one minor response (24 h after the third induction dose guinea Dig 84E0013 had a 0.5 score) there was no reaction observed in response to guanidine hydrochloride, either at 24 or 48 h.
This lack of response is reflected in Tables 3 and 4 , which report the severity of skin reactions at 24 and 48 h. Response severity for each group is calculated by summing the scores of responding animals and dividing by the total number of animals within that group. For n' h1 ~k . guanidine hydrochloride the only reponse was the 0.5 score mentioned above for animal 84E0013 following the third induction. This produced a severity index of 0.05 at 24 h.
In contrast, dinitrochlorobenzene (DNCB) produced a marked response at all time points after the first induction dose. Between 80% and 100% of the DNCB-treated animals exhibited a response 24 h following the second or third induction and challenge doses. These reactions persisted; they yielded scorable effects in 50 to 70% of the animals at 48 h after dosing.
Severity scores for these reponses to DNCB ranged from 0.7 to 1.25 at the 24 h scoring period ( Table 3) .
The highest score, 1.25, was observed on the left (induction) side in response to the challenge dose. By 48 h the reactions had subsided somewhat, with the severity r,. scores ranging from 0.45 to 0.6 (Table 4) .
No responses whatsoever were observed in the vehicle control (saline-treated) group or in the negative control (challenge dose of guanidine hydrochloride only) group. The individual 24-h and 48-h scores for all animals appear, by group, in Appendix D.
-. .. Most skin reactions occurring from contact with chemicals can be___ classified as either irritation or sensitization. Both reactions present as inflammation of the skin; the difference being the mechanism responsible for this inflammation.
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Primary irritation is direct inflammation in response to injury to -the skin produced by the eliciting chemical. Irritation Is a locally mediated response ranging from mild reversible inflammation to severe ulceration progressing to necrosis.
Sensitization is manifested as indirect inflammation mediated by components of the Immune system in response to activation by the eliciting chemical. Dermal sensitization is usually a delayedI hypersensitivity or cellular immunologic reaction. During the induction phase (3 weeks in the present study) there is proliferation of a clone of T lympl'ocytes specifically sensitized to the eliciting antigen. Upon subsequ nt exposure to the antigen, these T lymphocytes release mediators, lyMphoKines, which initiate and amplify an Inflammatory reaction at the site of contact (8).
Although both types of reactions can appear grossly similar in experimental animals, and may even be produced by the same agent, it is possible to distinguish between them. Irritation is an Immediate response and can be produced upon first contact vith the chemical, whereas sensitization requires at least one innocuous "conditioning" exposure before a reaction can be elicited.
Irritative responses usually require a relatively high concentration or dose of the offending chemical, while sensitization reactions may occur in response to minute quantities. Essentially all individuals in a population will express an irritative response to a reactive chemical, provided the dose is high enough, while only a fraction of the population normally becomes sensitized to the same chemical. A fully developed response can be produced by first contact . with an irritant, but Initial contact with a sensitizer produces no reaction (a conditioning exposure is necessary). Unless there is accumulition of damage, subsequent exposures to an irritant produce Inflammation of essentially similar intensity/severity, while the reaction to a a sensitizer increases over 2 to 4 exposures after the Initial contact. An irritant produces inflammation of rapid onset with short duration while a sensitization reaction is somewhat delayed p and prolonged. The inflammatory response to an irritant may spread beyond the area of contact while sensitization reactions are usually circumscribed.
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4-dT he features of Irritation and sensitization were applied by Buehler and Griffith (4-6) to establish guidelines for differentiation .r between the two. In evaluating a dermal sensitization study they * recommend comparing the results from a challenge dose in the experimental group with those for the negative control group:
Irritative Responses:
.
-occur in a large proportion of test animals.
-develop in response to the first or second exposure.
-usuiallv fade within 24 to 48 h, tinless damage Is severe.
-may be stronger at challenge to a previously unexposed area -of skin (contralateral flank).
Sensitization Reactions:
-occur in only a few animals, unless the compound is a d potent sensitizer.
-are absent after the initial (conditioning) exposure, but appear In response to subsequent exposures.
-develop slowly, the intensity/severity of inflammation being greater at 72 to 96 h than at 24 to 48 h.
-increase
In intensity/severity from one exposure to the %. next (at sites previously exposed or unexposed).
Dermal irritancy is evaluated by the method of Draize et al (9) in which the chemical is applied once, at high concentration, and the resulting acute inflammatory response is graded. Evaluation of sensitization potential is accomplished by repeated application, at lower non-irritating concentrations, over a few weeks. There is then a latent period, usually two weeks, to allow the immune system to elaborate and increase its specific reactivity to the chemical. A challenge dose is then given and the resulting inflammatory reaction Is~ graded. Analysis of the incidence, severity and timing of the -reaction to the challenge dose gives an estimate of the sensitizing potential of the study compound.
IY.
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. guamnidine hydrochl)ride prodwiced no responso Indicativle of dermal -sensitization. Therefore in this study, guanidine hydrochloride showed no evidence of potential to elicit an immunologic response.
Because the guinea pig exhibits a somewhat lower sensitizing responsiveness than man, the results we observed do not guarantee that,..-'' guanidine hydrochloride will not sensitize humans. They do indicate that guanidine hydrochloride is unlikely to sensitize humans and the -potential is low enough to permit testing in humans.
Any sensitization produced by guanidine hydrochloride would have been easily detected by this study. A hypersensitivity-type response . was reliably elicted by DNCB in the present group of animals. This response to DNCB was characteristic of that observed previously within -J the Institute (10).
klthough DNCB is capable of producing primary irritation, the characteristics of responses observed in this study are indicative of a reaction due to sensitization. The concentration of INCR used for Induction and challenge Is too low to produce primary irritation. Also the response to DNCB was observed only after two or more exposures and the severity generally increased with the number of previous exposures.
CONCLUSION
Guanidine hydrochloride, based on a zero percent sensitization rate in this study, exhibited no potential for inducing dermal . sensitization.
RECOMMENDATION
Additional toxicological testing should be conducted on guanidine hydrochloride.
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Cl. Forty-six animals arrived, were examined, placed in cages, and W b fed.
LO May 84
Animals ear-tagged and weighed. Two animals submitted for necropsy as quality controls. 
